Inventor
ELLEN CHI
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides36%
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
PatentTitleYear
12,162,951Anti-idiotypic antibodies against anti-KLK2 antibodies202412,134,636Immunoglobulins and uses thereof202412,030,937Anti-idiotypic antibodies against anti-GPRC5D antibodies202411,780,900Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof202311,767,354Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors202311,746,157PSMA binding agents and uses thereof202311,591,379Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors202311,401,315Immunoglobulins and uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to JANSSEN PHARMACEUTICA NV (4)· patent assignee history
2022–2024Based in US· patent location history
2023–2024Patents assigned to JANSSEN BIOTECH INC (3)· patent assignee history
2023Patents assigned to JANSSEN SCIENCES IRELAND UNLIMITED CO (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JANSSEN PHARMACEUTICA NV | 4 | 2022–2024 |
| JANSSEN BIOTECH INC | 3 | 2023–2024 |
| JANSSEN SCIENCES IRELAND UNLIMITED CO | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2022–2024 |